ID   LN229/CD20
AC   CVCL_A8V5
DR   cancercelllines; CVCL_A8V5
DR   Wikidata; Q102114467
RX   PubMed=32667234;
RX   PubMed=32724441;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: HGNC; 7315; MS4A1 (with a N-terminal GVAMPGAEDDVV = PA-tag).
CC   Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 7
//
RX   PubMed=32667234; DOI=10.1089/mab.2020.0015;
RA   Furusawa Y., Kaneko M.K., Kato Y.;
RT   "Establishment of an anti-CD20 monoclonal antibody (C20Mab-60) for
RT   immunohistochemical analyses.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 39:112-116(2020).
//
RX   PubMed=32724441; DOI=10.3892/ol.2020.11753;
RA   Furusawa Y., Kaneko M.K., Kato Y.;
RT   "Establishment of C20Mab-11, a novel anti-CD20 monoclonal antibody, for
RT   the detection of B cells.";
RL   Oncol. Lett. 20:1961-1967(2020).
//